The global breast cancer liquid biopsy market is to increase from US$ 268.3 million in 2020 to US$ 677.3 million by 2025 with a compound annual growth rate (CAGR) of 20.3% for the period 2020-2025. The development of new cancer drugs by making viable treatment choices due to increased research and development (R&D) activities catalyse the market growth for breast cancer liquid biopsy.  It is used to recognize or catch the intact genomics history of breast cancers, or to diagnose cancerous biomarkers at an early stage to better provide successful prevention and healthcare services. According to the World Health Organisation (WHO), breast cancer is one of the most prevalent forms of cancer in women, with about 2.1 million women suffering from breast cancer each year. Also, in 2018, nearly 627,000 people died of breast cancer. As a result, the increased case of breast cancer is expected to accelerate the need for breast cancer liquid biopsy. The research report on the global breast cancer liquid biopsy industry provides extensive competition analysis and competitive conditions. The report includes information on significant products, players, challenges and developments, and other information specific to the breast cancer liquid biopsy industry. The data in this report is targeted for business and industry practitioners and specifically intended to assist in the explanation, direction, and to understand of the potential of the breast cancer liquid biopsy markets. The study focuses on providing readers with an understanding of developments in the industry, market segments, market forecasts, leading players, and market drivers and inhibitors.

1. www.dhirtekbusinessresearch.com
sales@dhirtekbusinessresearch.com
+91 7580990088
Breast Cancer Liquid Biopsy
Market
Global Industry Analysis & Forecast US$
Million, 2019 – 2027

2. © Dhirtek Business Research and Consulting Private Limited www.dhirtekbusinessresearch.com
Global Breast Cancer Liquid Biopsy Market
2
Scope of the Report
 Global Breast Cancer Liquid Biopsy Market, By Circulating Biomarker
 Circulating Tumor Cells (CTCs)
 Cell-free DNA (cfDNA)
 Extracellular Vesicles (EVs)
 Other Circulating Biomarkers
 Global Breast Cancer Liquid Biopsy Market, By End-User
 Reference Laboratories
 Hospitals and Physicians Laboratories
 Others
 Global Breast Cancer Liquid Biopsy Market, By Region
 North America Breast Cancer Liquid Biopsy Market
 Europe Breast Cancer Liquid Biopsy Market
 Asia Pacific Breast Cancer Liquid Biopsy Market
 Middle East & Africa Breast Cancer Liquid Biopsy Market
 Latin America Breast Cancer Liquid Biopsy Market
 Company
 Biodesix, Inc.
 Cynvenio Biosystems, Inc.
 Fluxion Biosciences, Inc.
 Genomic Health, Inc.
 Illuma,Inc.
 Menarini Silicon Biosystems
 Myriad Genetics
 QIAGEN N.V.
 Roche Diagnostics
 Thermo Fisher Scientific Inc.

3. © Dhirtek Business Research and Consulting Private Limited www.dhirtekbusinessresearch.com
Global Breast Cancer Liquid Biopsy Market
3
Regions Covered
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
Japan
India
S. Korea
Indonesia
Australia & New
Zealand
ASEAN Countries
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa

4. © Dhirtek Business Research and Consulting Private Limited www.dhirtekbusinessresearch.com
Global Breast Cancer Liquid Biopsy Market
Global Breast Cancer Liquid Biopsy Market Introduction
4
The global breast cancer liquid biopsy market is to increase from US$ 268.3 million in 2020 to US$ 677.3 million by
2025 with a compound annual growth rate (CAGR) of 20.3% for the period 2020-2025. The development of new cancer
drugs by making viable treatment choices due to increased research and development (R&D) activities catalyse the
market growth for breast cancer liquid biopsy. It is used to recognize or catch the intact genomics history of breast
cancers, or to diagnose cancerous biomarkers at an early stage to better provide successful prevention and healthcare
services. According to the World Health Organisation (WHO), breast cancer is one of the most prevalent forms of
cancer in women, with about 2.1 million women suffering from breast cancer each year. Also, in 2018, nearly 627,000
people died of breast cancer. As a result, the increased case of breast cancer is expected to accelerate the need for
breast cancer liquid biopsy. The research report on the global breast cancer liquid biopsy industry provides extensive
competition analysis and competitive conditions. The report includes information on significant products, players,
challenges and developments, and other information specific to the breast cancer liquid biopsy industry. The data in
this report is targeted for business and industry practitioners and specifically intended to assist in the explanation,
direction, and to understand of the potential of the breast cancer liquid biopsy markets. The study focuses on
providing readers with an understanding of developments in the industry, market segments, market forecasts, leading
players, and market drivers and inhibitors.
Goals and objectives of the study
Define key market trends, innovations, opportunities, and factors influencing the global breast cancer liquid
biopsy market and its sub-segments.
Identify and analyze primary industry categories and their respective frameworks for the breast cancer liquid

5. © Dhirtek Business Research and Consulting Private Limited www.dhirtekbusinessresearch.com
Global Breast Cancer Liquid Biopsy Market
Global Breast Cancer Liquid Biopsy Market Introduction
5
biopsy global market.
Predict the total size of the breast cancer liquid biopsy market internationally and analyze it based on the
circulating biomarkers, end-users and region.
Classify primary players and assess the business environment based on recent developments and segment
revenue.
Chapter 2, "Market Overview" provides an overview of the breast cancer liquid biopsy market. The chapter includes
macro-economic factors, market determinants (includes market drivers, restraints, opportunities, and challenges),
value chain analysis, technology/product roadmap, Porter 5 force model analysis, market growth opportunity analysis.
Chapter 3 "Segment Analysis" of the study deals with the different sub-segments of the market to calculate reliable
market forecasts. The breast cancer liquid biopsy market was segmented based on circulating biomarkers and end-
users. The chapter provides an in-depth analysis of the market segments of the breast cancer liquid biopsy market,
year-on-year growth projections that enable readers to identify potential market growth areas.
Market Segmentation
Based on circulating biomarkers, the global demand for breast cancer liquid biopsy is segmenting into circulating
tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs).
Based on end-users, the market is segmenting into reference laboratories, hospitals and physicians laboratories
and others.
Chapter 4, "Regional Analysis" includes an in-depth analysis of the breast cancer liquid biopsy market by regions such
as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. The report also includes a

6. © Dhirtek Business Research and Consulting Private Limited www.dhirtekbusinessresearch.com
Global Breast Cancer Liquid Biopsy Market
Global Breast Cancer Liquid Biopsy Market Introduction
6
comprehensive analysis of the market in key countries such as the United States, Canada, Germany, France, Italy,
Spain, China, India, Japan, the GCC, South Africa, Brazil, Mexico, and the rest of the world. Regional insight helps
market competitors to make crucial decisions about their company. Individualized, country-wise, and segment-wise
analyses by region allow readers of the breast cancer liquid biopsy market report to explore the potential of the
market in different geographies. For each year's growth projections and a global share of value, this section is a vital
part of the report.
Chapter 5 "Competitive Analysis" of the report includes company shares analysis, a list of acquisitions, mergers,
collaboration, and the introduction of new products.
Chapter 6 "Company Profile" of the report also covers key industry players working on the breast cancer liquid biopsy
market. Some of the prominent competitors in the breast cancer liquid biopsy market are QIAGEN N.v., Roche
Diagnostics, Illuma,Inc., Myriad Genetics, Menarini Silicon Biosystems, Cynvenio Biosystems, Inc., Genomic Health,
Inc., Thermo Fisher Scientific Inc., Fluxion Biosciences, Inc. and Biodesix, Inc. The report also discusses the business
strategies adopted by the players at the global, regional, and country-level. The study also focuses on various
businesses or inorganic business development strategies for expanding consumer networks through product
formation, organization extension, partnerships, mergers, and acquisitions.
The study offers an exhaustive summary and estimate of the global breast cancer liquid biopsy market. It includes in-
depth qualitative and quantitative analyses in the report that aligned with the goals and objectives of our customers.
Projections have been confirmed by comprehensive primary and secondary analysis. The study will encourage clients
to invest in the breast cancer liquid biopsy market based on the current business situation, trends, and potential

7. © Dhirtek Business Research and Consulting Private Limited www.dhirtekbusinessresearch.com
Global Breast Cancer Liquid Biopsy Market
Global Breast Cancer Liquid Biopsy Market Introduction
7
developments in the segments. Understanding the requirement of the client, the report delivers specialist insights into
the global breast cancer liquid biopsy market, its products, and market patterns.

8. © Dhirtek Business Research and Consulting Private Limited www.dhirtekbusinessresearch.com
Global Breast Cancer Liquid Biopsy Market
Global Breast Cancer Liquid Biopsy Market Introduction
Global Breast Cancer Liquid Biopsy Market Size, US$ Million (2020
– 2027)
XX XX
XX
XX
XX
XX
XX XX
XX
2019 2020 2021 2022 2023 2024 2025 2026 2027
Global Breast Cancer Liquid Biopsy Market Opportunity Analysis
Size, US$ Million (2020 – 2027)
8
Source: Secondary Literature, Expert Interviews, and Dhirtek Business Research Analysis Source: Secondary Literature, Expert Interviews, and Dhirtek Business Research Analysis
XX%
XX% XX%
XX% XX%
XX%
XX% XX%
XX XX
XX
XX
XX
XX
XX
XX
XX
2019 2020 2021 2022 2023 2024 2025 2026 2027
Total Opportunity

9. © Dhirtek Business Research and Consulting Private Limited www.dhirtekbusinessresearch.com
Global Breast Cancer Liquid Biopsy Market
Global Breast Cancer Liquid Biopsy Market Introduction
Global Breast Cancer Liquid Biopsy Market Share Analysis, by
Circulating Biomarker, (2020 & 2027)
Global Breast Cancer Liquid Biopsy Market Share Analysis, by End-
User, (2020 & 2027)
9
Source: Secondary Literature, Expert Interviews, and Dhirtek Business Research Analysis Source: Secondary Literature, Expert Interviews, and Dhirtek Business Research Analysis
XX%
XX%
XX%
XX%
XX%
XX%
XX%
XX%
Circulating Tumor Cells (CTCs) Cell-free DNA (cfDNA)
Extracellular Vesicles (EVs) Other Circulating Biomarkers
2020
2027
2020
2027
XX%
XX%
XX%
XX%
XX%
XX%
Reference Laboratories
Hospitals and Physicians Laboratories
Others

10. © Dhirtek Business Research and Consulting Private Limited www.dhirtekbusinessresearch.com
Global Breast Cancer Liquid Biopsy Market
Global Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
Global Breast Cancer Liquid Biopsy Market Analysis and Forecast, by Circulating Biomarker, US$ Million (2020 – 2027)
Circulating Biomarker 2019 2020 2021 2022 2023 2024 2025 2026 2027
CAGR % (2020 –
2027)
Circulating Tumor Cells
(CTCs)
XX XX XX XX XX XX XX XX XX XX
Cell-free DNA (cfDNA) XX XX XX XX XX XX XX XX XX XX
Extracellular Vesicles
(EVs)
XX XX XX XX XX XX XX XX XX XX
Other Circulating
Biomarkers
XX XX XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX XX XX
10
Source: Secondary Literature, Expert Interviews, and Dhirtek Business Research Analysis

11. © Dhirtek Business Research and Consulting Private Limited www.dhirtekbusinessresearch.com
Global Breast Cancer Liquid Biopsy Market
Global Breast Cancer Liquid Biopsy Market, by End-User
Global Breast Cancer Liquid Biopsy Market Analysis and Forecast, by End-User, US$ Million (2020 – 2027)
End-User 2019 2020 2021 2022 2023 2024 2025 2026 2027
CAGR % (2020 –
2027)
Reference Laboratories XX XX XX XX XX XX XX XX XX XX
Hospitals and Physicians
Laboratories
XX XX XX XX XX XX XX XX XX XX
Others XX XX XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX XX XX
11
Source: Secondary Literature, Expert Interviews, and Dhirtek Business Research Analysis

12. © Dhirtek Business Research and Consulting Private Limited www.dhirtekbusinessresearch.com
Global Breast Cancer Liquid Biopsy Market
Global Breast Cancer Liquid Biopsy Market, by Region
12
XX
XX XX
XX XX
XX
XX
XX
XX XX
North America Europe Asia Pacific Middle East & Africa Latin America
US$ Million
2020 2027
XX%
XX%
XX%
XX%
XX%
XX%
XX%
XX%
XX% XX%
North America
Europe
Asia Pacific
Middle East & Africa
Latin Maerica
2020
2027
Source: Secondary Literature, Expert Interviews, and Dhirtek Business Research Analysis

13. © Dhirtek Business Research and Consulting Private Limited www.dhirtekbusinessresearch.com
Global Breast Cancer Liquid Biopsy Market
Global Breast Cancer Liquid Biopsy Market, by Region
Global Breast Cancer Liquid Biopsy Market Analysis and Forecast, by Region, US$ Million (2020 – 2027)
Region 2019 2020 2021 2022 2023 2024 2025 2026 2027
CAGR % (2020 –
2027)
North America XX XX XX XX XX XX XX XX XX XX
Europe XX XX XX XX XX XX XX XX XX XX
Asia Pacific XX XX XX XX XX XX XX XX XX XX
Middle East & Africa XX XX XX XX XX XX XX XX XX XX
Latin America XX XX XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX XX XX
13
Source: Secondary Literature, Expert Interviews, and Dhirtek Business Research Analysis

14. © Dhirtek Business Research and Consulting Private Limited www.dhirtekbusinessresearch.com
Global Breast Cancer Liquid Biopsy Market, Company Share Analysis, 2020 (%)
14
Global Breast Cancer Liquid Biopsy Market
XX%
XX%
XX%
XX%
XX%
XX%
XX%
XX%
XX%
XX%
XX%
Biodesix, Inc.
Cynvenio Biosystems, Inc.
Fluxion Biosciences, Inc.
Genomic Health, Inc.
Illuma,Inc.
Menarini Silicon Biosystems
Myriad Genetics
QIAGEN N.V.
Roche Diagnostics
Thermo Fisher Scientific Inc.
Others

15. © Dhirtek Business Research and Consulting Private Limited www.dhirtekbusinessresearch.com
Global Breast Cancer Liquid Biopsy Market
15
For Sample Report:
https://www.dhirtekbusinessresearch.com/market-
report/Breast-Cancer-Liquid-Biopsy-Market-Analysis--
Forecast-2020--2025/request-for-sample-report

16. Thank you
sales@dhirtekbusinessresearch.com
www.dhirtekbusinessresearch.com
Office No. 207, 2nd Floor, Navrang Plaza, Sapna Sangeeta
Road, Indore, M.P., 452001
+91 7580990088